Study of the Treatment of Algerian Patients With Early Rheumatoid Arthritis

Case Study of the Treatment of Early Rheumatoid Arthritis in Algerian Patients in Both the Private and Public Healthcare Sectors.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02008266

Enrollment

532

Registered

2013-12-11

Start date

2011-09-30

Completion date

2012-12-31

Last updated

2013-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

This non-interventional, descriptive, cross-sectional and multicenter study will examine the treatment of rheumatoid arthritis progressing for less than two years in the Algerian population. Current drug therapy as well as disease status and patient function will be assessed.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Rheumatoid arthritis progressing for \< 2 years.

Exclusion criteria

* Rheumatoid arthritis progressing for \< 3 months. * Rheumatoid arthritis onset at \< 18 years of age. * Participation in another clinical study. * Rheumatoid arthritis related connective tissue disorder. * Any neuropsychological disorders.

Design outcomes

Primary

Measure	Time frame
Describe medications used in the treatment of rheumatoid arthritis with < 2 years' progression.	Single observational visit [Day 1]

Secondary

Measure	Time frame
Measure disease activity using DAS 28 assessment.	Single observational visit [Day 1]
Assess joint damage using the modified SHARP method.	Single observational visit [Day 1]
Assess functional status of patients using the Health Assessment Questionnaire (HAQ).	Single observational visit [Day 1]

Outcome results